These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Aminoalkyl adenylate and aminoacyl sulfamate intermediate analogues differing greatly in affinity for their cognate Staphylococcus aureus aminoacyl tRNA synthetases. Forrest AK; Jarvest RL; Mensah LM; O'Hanlon PJ; Pope AJ; Sheppard RJ Bioorg Med Chem Lett; 2000 Aug; 10(16):1871-4. PubMed ID: 10969988 [TBL] [Abstract][Full Text] [Related]
6. Inhibition by L-aspartol adenylate of a nondiscriminating aspartyl-tRNA synthetase reveals differences between the interactions of its active site with tRNA(Asp) and tRNA(Asn). Bernard D; Akochy PM; Bernier S; Fisette O; Brousseau OC; Chênevert R; Roy PH; Lapointe J J Enzyme Inhib Med Chem; 2007 Feb; 22(1):77-82. PubMed ID: 17373551 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of 8-aminoadenosine 5'-(aminoalkyl phosphates), analogues of aminoacyl adenylates. Yousefi-Salakdeh E; Murtola M; Zetterberg A; Yeheskiely E; Strömberg R Bioorg Med Chem; 2006 Apr; 14(8):2653-9. PubMed ID: 16368242 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of glutaminyl adenylate analogues that are inhibitors of glutaminyl-tRNA synthetase. Bernier S; Dubois DY; Therrien M; Lapointe J; Chênevert R Bioorg Med Chem Lett; 2000 Nov; 10(21):2441-4. PubMed ID: 11078196 [TBL] [Abstract][Full Text] [Related]
9. Covalent aspartylation of aspartyl-tRNA synthetase from bakers' yeast by its cognate aspartyl adenylate: identification of the labeled residues. Mejdoub H; Kern D; Giegé R; Ebel JP; Boulanger Y; Reinbolt J Biochemistry; 1987 Apr; 26(7):2054-9. PubMed ID: 3297142 [TBL] [Abstract][Full Text] [Related]
10. Investigation of bioisosteric effects on the interaction of substrates/ inhibitors with the methionyl-tRNA synthetase from Escherichia coli. Vaughan MD; Sampson PB; Daub E; Honek JF Med Chem; 2005 May; 1(3):227-37. PubMed ID: 16787318 [TBL] [Abstract][Full Text] [Related]
11. Nanomolar inhibition of the enterobactin biosynthesis enzyme, EntE: synthesis, substituent effects, and additivity. Callahan BP; Lomino JV; Wolfenden R Bioorg Med Chem Lett; 2006 Jul; 16(14):3802-5. PubMed ID: 16678412 [TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of pyrimidine substituted aminoacyl-sulfamoyl nucleosides as potential inhibitors targeting class I aminoacyl-tRNA synthetases. Nautiyal M; De Graef S; Pang L; Gadakh B; Strelkov SV; Weeks SD; Van Aerschot A Eur J Med Chem; 2019 Jul; 173():154-166. PubMed ID: 30995568 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationships of a series of novel thiazoles as inhibitors of aminoacyl-tRNA synthetases. Yu XY; Hill JM; Yu G; Wang W; Kluge AF; Wendler P; Gallant P Bioorg Med Chem Lett; 1999 Feb; 9(3):375-80. PubMed ID: 10091687 [TBL] [Abstract][Full Text] [Related]
14. Glutamylsulfamoyladenosine and pyroglutamylsulfamoyladenosine are competitive inhibitors of E. coli glutamyl-tRNA synthetase. Bernier S; Dubois DY; Habegger-Polomat C; Gagnon LP; Lapointe J; Chênevert R J Enzyme Inhib Med Chem; 2005 Feb; 20(1):61-7. PubMed ID: 15895686 [TBL] [Abstract][Full Text] [Related]
15. Domain-domain communication for tRNA aminoacylation: the importance of covalent connectivity. Zhang CM; Hou YM Biochemistry; 2005 May; 44(19):7240-9. PubMed ID: 15882062 [TBL] [Abstract][Full Text] [Related]
16. Mechanism of a GatCAB amidotransferase: aspartyl-tRNA synthetase increases its affinity for Asp-tRNA(Asn) and novel aminoacyl-tRNA analogues are competitive inhibitors. Huot JL; Balg C; Jahn D; Moser J; Emond A; Blais SP; Chênevert R; Lapointe J Biochemistry; 2007 Nov; 46(45):13190-8. PubMed ID: 17929881 [TBL] [Abstract][Full Text] [Related]
17. Aspartyl phosphonates and phosphoramidates: the first synthetic inhibitors of bacterial aspartate-semialdehyde dehydrogenase. Cox RJ; Gibson JS; Mayo Martín MB Chembiochem; 2002 Sep; 3(9):874-86. PubMed ID: 12210989 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13. Liu Y; Shang L; Fang H; Zhu H; Mu J; Wang Q; Wang X; Yuan Y; Xu W Bioorg Med Chem; 2009 Oct; 17(20):7398-404. PubMed ID: 19782572 [TBL] [Abstract][Full Text] [Related]
19. Aminoacyl-tRNA synthetase inhibitors as potent and synergistic immunosuppressants. Van de Vijver P; Ostrowski T; Sproat B; Goebels J; Rutgeerts O; Van Aerschot A; Waer M; Herdewijn P J Med Chem; 2008 May; 51(10):3020-9. PubMed ID: 18438987 [TBL] [Abstract][Full Text] [Related]
20. Characterization of inhibitors acting at the synthetase site of Escherichia coli asparagine synthetase B. Boehlein SK; Nakatsu T; Hiratake J; Thirumoorthy R; Stewart JD; Richards NG; Schuster SM Biochemistry; 2001 Sep; 40(37):11168-75. PubMed ID: 11551215 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]